Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: A systematic review and meta-analysis

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Kwok, Chun Shing ^a   Ao, Sunil V ^b   Myint, Phyo K ^c   Keavney, Bernard ^a   Nolan, James ^d   Ludman, Peter F ^e   Belder, Mark A De ^f   Loke, Yoon K ^g   Mamas, Mamas A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^e Queen Lizabeth Hospital   (United Kingdom)

^f JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CARDIOVASCULAR DISEASE; DISEASE CLASSIFICATION; DRUG ELUTING STENT; HUMAN; MORTALITY; MORTALITY RISK; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 85006862429     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2013-000021     Document Type: Review

References (69)

1. Lincoff AM, Kleiman NS, Kereiakes DJ, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004;292:696-703.
2. Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 2011;4:654-64.
3. Subherwal S, Peterson ED, Dai D, et al. Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: A report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol 2012;59:1861-9.
4. Mehta SR, Jolly SS, Cairns, et al. RIVAL Investigators. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol 2012;60:2490-9.
5. Mehran R, Pocock SJ, Stone GW, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: A risk model from the ACUITY trial. Eur Heart J 2009;30:1457-66.
6. Happe LE, Rao SV, Horblyuk R, et al. Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants. Curr Med Res Opin 2009;25:413-20.
7. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30.
8. Giugliano RP, Giraldez RR, Morrow DA, et al. Relationship between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J 2010;31:2103-10.
9. Rao SV, Mehran R. Evaluating the bite of the BARC. Circulation 2012;125:1344-6.
10. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium. Circulation 2011;123:2736-47.
11. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-5.
12. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY trial. J Am Coll Cardiol 2007;49:1362-8.
13. Rao SV, Eikelboom JA, Granger CB, et al. Bleeding and blood transfusion issues inpatients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1193e204.
14. Chhatriwalla AK, Amin AP, Kennedy KF, et al. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA 2013;309:1022-9.
15. Spencer FA, Moscucci M, Granger CB, et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction Circulation 2007;116:2793-801.
16. Berger PB, Manoukian SV. Bleeding is badisn't it Circulation 2007;116:2776-8.
17. Ndrepepa G, Schulz S, Keta D, et al. Bleeding after percutaneous coronary intervention with bivalirudin or unfractionated heparin and one-year mortality. Am J Cardiol 2010;105:163-7.
18. Cayla G, Silvain J, Barthelemy O, et al. Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: An analysis of major bleeding complications in the ABOARD Study. Heart 2011;97:887-91.
19. Valente S, Lazzeri C, Chiostri M, et al. STEMI patients-the more you bleed, the more you die: A comparison between classifications. Clin Cardiol 2011;34:90-6.
20. Barthélémy O, Silvain J, Brieger D, et al. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center. Catheter Cardiovasc Interv 2012;79:104-12.
21. Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009;10:88-93.
22. Hermanides RS, Ottervanger JP, Dambrink JH, et al. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction. EuroIntervention 2010;6:106-11.
23. Ndrepepa G, Schuster T, Hadamitzky M, et al. Validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 2012;125:1424-31.
24. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-6.
25. Montalescot G, Gallo R, White HD, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv 2009;2:1083-91.
26. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:809-16.
27. Lemesle G, Labriolle AD, Bonello L, et al. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention. Cather Cardiovasc Interv 2009;74:428-35.
28. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82.
29. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry test for publication bias in meta-analyses: A large survey. CMAJ 2007;176:1091-6.
30. Davies HT, Crombie IK, Tavakoli M. When odds ratios mislead BMJ 1998;316:989-91.
31. Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S. eds. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, 2008. http://handbook. cochrane. org/chapter-9/9-5-2-identifying-and- measuring-heterogeneity. htm
32. Amlani S, Nadarajah T, Afzal R, et al. Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction. J Thromb Thrombolysis 2010;30:434-40.
33. Ariza-Sole A, Sanchez-Elvira G, Sanchez-Salado JC, et al. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res 2013;132:652-8.
34. Bertrand OF, Larose E, Rodés-Cabau J, et al. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. Am Heart J 2009;157: 164-9.
35. Boden H, Velders M, van der Hoeven, et al. The risk of in-hospital bleeding and long-term mortality in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2012;60:B161-2.
36. Budaj A, Wikelboom JW, Mehta SR, et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndrome. Eur Heart J 2009;30:655-1.
37. Cayla G, Barthelemy O, Silvain J, et al. Anticoagulation, arterial access and bleeding in primary PCI: An analysis of the randomized ATOLL trial. Eur Heart J 2012;33:462.
38. Correia LC, Sabino M, Brito M, et al. Causality analysis of the relationship between bleeding and lethality in acute coronary syndrome. Arq Bras Cardiol 2012;98:488-96.
39. Gitt AK, Bauer T, Hochadel MG, et al. Impact of radial arterial access for PCI in acute coronary syndromes on bleeding complications in clinical practice: results of the Euro Heart Survey PCI-registry. Eur Heart J 2010;31(Suppl 1):659.
40. Kaul P, Tanguay JF, Newby LK, et al. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the early versus delayed, provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial. Am Heart J 2013;166:723-8.
41. Kikkert WJ, Zwindermann AH, Vis MM, et al. Timing of mortality after severe bleeding and recurrent myocardial infarction in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2013;6:391-8.
42. Le May M, MacDougall A, So D, et al. Impact of bleeding on mortality in patients referred for primary PCI in ST-elevation myocardial infarction. Can J Cardiol 27(5 Suppl 1):S219.
43. Lee JY, Kim YH, Kim WJ, et al. Long-term clinical impact of bleeding after percutaneous coronary intervention with drug-eluting stent in real world practice. J Am Coll Cardiol 2009;53:A45.
44. Lindsey JB, Marso SP, Pencina M, et al. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients. Results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2009;2:1074-82.
45. Lopes RD, Subherwal S, Holmes DN, et al. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST segment myocardial infarction. Eur Heart J 2012;33:2044-53.
46. Matic D, Mrdovic I, Stankovic G, et al. Incidence, predictors and prognostic implications of bleeding complicating contemporary primary percutaneous coronary interventions. Eur Heart J 2010;31 (Suppl 1):5.
47. Matic D, Stankovic G, Antonijevic N, et al. Prognostic implications of bleeding complicating STEMI treated with primary percutaneous coronary intervention. Eur Heart J 2011;32(Suppl 1):394.
48. Matic D, Milasinovic D, Asanin M, et al. Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorization in patients treated with primary percutaneous coronary intervention. Eur Heart J 2012;33(Suppl 1):208-9.
49. Mrdovic I, Savic L, Asanin M, et al. Sex-related analysis of shortand long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: An evaluation of the RISK-PCI data. Can J Cardiol 2013;29: 1097-103.
50. Musumeci G, Rossini R, Lettieri C, et al. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Catheter Cardiovasc Interv 2012;80:395-405.
51. Pierre-Louis B, Aronow WS, Yoon JH, et al. Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes. Am J Ther 2010;17:e74-7.
52. Pilgrim TM, Wenaweser P. Impact of bleeding on clinical outcome in patients undergoing PCI. Eur H J 2010;31(Suppl 1):658.
53. Polanska-Skrzypczyk M, Karcz M, Bekta P, et al. Major bleeding is a predictor of mid-term mortality in STEMI patients treated with primary PCI. The ANIN myocardial infarction registry. Eur Heart J 2011;32 (Suppl 1):876-7.
54. Poludasu S, Baber U, Clark AE, et al. Impact of major bleeding on long term mortality in patients with and without anemia undergoing percutaneous coronary intervention with bivalirudin. TCT Abstracts JACC 2011;58(20 Suppl B):B17.
55. Rossini R, Musumeci G, Lettieri C, et al. Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation. Eur Heart J 2010;31(Suppl 1):167.
56. Urban P, Abizaid A, Banning A, et al. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: A report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol 2011;57:1445-54.
57. Yoon YH, Kim YH, Park KM, et al. Impact of in-hospital bleeding on major adverse cardiac events and stroke using bleeding academic research consortium classification in patients who undergoing percutaneous coronary intervention. Am J Cardiol 2013;111 (Suppl 7):91B.
58. Zheng HC, Q Zhang Q, Zhang RY, et al. Clinical outcomes of patients with major bleeding after primary coronary intervention for acute ST-segment elevation myocardial infarction. J Interv Radiol 2009;18:808-11.
59. Mehta SK, Frutkin AD, Lindsey JB, et al. Bleeding in patients undergoing percutaneous coronary intervention: The development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2009;2:222-9.
60. Dangas GD, Claessen BE, Mehran R, et al. Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 2012;59:1752-9.
61. Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding blood transfusion and increased mortality after percutaneous coronary intervention. J Am Coll Cardiol 2009;53:2019-27.
62. Smith KJ, Bleyer AJ, Little WC, et al. The cardiovascular effects of erythropoietin. Cardiovasc Res 2003;59:538-48.
63. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007;357:965-76.
64. Najjar SS, Rao SV, Melloni C, et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: A randomized controlled trial. JAMA 2011;305:1863-72.
65. Chase AJ, Fretz EB, Warburton WP, et al. Association of the arterial access site at angioplasty with transfusion and mortality: The M. O. R. T. A. L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-25.
66. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62.
67. Yacoub D, Hachem A, Théorêt JF, et al. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol 2010;30:2424-33.
68. Robinson SD, Janssen C, Fretz EB, et al. Non-red blood cell transfusion as a risk factor for mortality following percutaneous coronary intervention. Int J Cardiol 2012;157:169-73.
69. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomised, parallel group, multicentre trial. Lancet 2011;377:1409-20.